Skip to main content
AVNS logo

Avanos Medical, Inc.

AVNSNYSEHealthcareMedical Devices

$24.99Today:- (-)1Y +111.96%

As of Jul 24, 2026 close

Market cap
$1.19B
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$10.64$25.49
Volume (live)
-
Avg. volume (3M)
2.06M

AVNS was delisted on Oct 24, 2026. Data shown is historical and no longer updated.

Avanos Medical (AVNS) Key Statistics & Financial Metrics

Complete stock analysis with 60+ metrics: valuation ratios, profitability margins, financial health indicators, and dividend data.

Stock Valuation Metrics

Market value, earnings multiples, and pricing ratios

Stock Price

Current price, 52-week range, and moving averages

Current Price$24.99
1-Day Change+0.04%
52-Week High$25.49
52-Week Low$10.64
YTD Change+123.52%
1-Year Change+111.96%
50-Day MA$24.90
200-Day MA$16.92
Avg Volume (30 day)2.06M

Profitability & Financial Performance

Profit margins, return metrics, and earnings analysis

Growth Rates (YoY)

Year-over-year growth metrics

Revenue Growth+3.87%

Financial Health & Dividends

Balance sheet analysis, debt ratios, and dividend metrics

Source: Market prices and company fundamentals from financial filings. Data as of Jul 24, 2026. Data sources and methodology

Frequently Asked Questions About Avanos Medical Statistics

What are the key financial metrics for AVNS?

Avanos Medical, Inc. (AVNS) statistics include 60+ financial metrics organized into valuation ratios (P/E, P/S, P/B, PEG), profitability margins (gross, operating, net), return metrics (ROE, ROA, ROIC), and financial health indicators. These are updated regularly based on the latest filings and market data.

What is AVNS's valuation analysis?

The valuation section covers market capitalization, earnings multiples like trailing and forward P/E, price-based ratios (P/S, P/B, Price/FCF), and enterprise value ratios (EV/EBITDA, EV/Revenue, EV/FCF). Compare these against sector averages to assess whether Avanos Medical is overvalued or undervalued.

How do I read AVNS's profitability ratios?

Avanos Medical's profitability is measured through profit margins (gross, EBITDA, operating, net) and return metrics (ROE, ROA, ROIC, ROCE). Higher margins indicate better cost control, while higher returns show efficient capital deployment. The income statement and cash flow sections provide the underlying revenue and earnings data.

What do AVNS's debt ratios indicate?

The financial health section shows Avanos Medical's leverage through debt-to-equity, debt-to-assets, debt-to-EBITDA, and debt-to-FCF ratios, plus liquidity via the current and quick ratios. Lower debt ratios and higher liquidity ratios generally indicate stronger financial stability and lower default risk.

What is AVNS's dividend analysis?

The dividend section covers Avanos Medical's dividend yield, payout ratios (earnings-based and FCF-based), year-over-year dividend growth, years of consecutive growth, ex-dividend and pay dates, and payment frequency. The yield metrics section also includes earnings yield, FCF yield, buyback yield, and total shareholder yield.